{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:42:57Z","timestamp":1792762977443,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lasers Med Sci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Purpose Scarring following acne, burns, and trauma remains a significant clinical and psychosocial challenge. Despite increasing clinical use, there is no consensus on the efficacy and safety of Ablative Fractional CO\u2082 Laser (AFCL) combined with Platelet-Rich Plasma (PRP) across scar aetiologies. This systematic review evaluated the efficacy and safety of AFCL with PRP for chronic acne, traumatic, and burn scars. Methods MEDLINE (PubMed) and Embase (Ovid) were searched to 1 September 2025 using terms related to scars, fractional CO\u2082 laser, and platelet-rich plasma. Eligible studies included human subjects treated with AFCL (10,600\u00a0nm) and autologous PRP delivered topically or intradermally. Studies using platelet-rich fibrin, PRP gel, or non-synchronous administration were excluded. Risk of bias was assessed using RoB 2 and ROBINS-I. Results Seventeen studies (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009420) met inclusion criteria. Nine (53%) were randomised studies, six (29%) non-randomised, and two (12%) retrospective. AFCL settings ranged from 10 to 30\u00a0W, dwell times 0.1\u20131.54 ms, and spot spacing 0.5\u20132.0\u00a0mm. PRP was predominantly prepared via double-spin centrifugation and delivered topically (47%) or intradermally (59%). AFCL+PRP showed superior efficacy to AFCL alone, with significant improvements in scar texture, pigmentation, erythema, and depth. Patient satisfaction was consistently higher with combination therapy, and topical PRP notably reduced downtime, suggesting accelerated repair and modulated inflammation. Conclusions AFCL combined with PRP enhances scar remodelling and patient outcomes while reducing complications. Heterogeneity in laser parameters, PRP preparation, and outcome measures limits direct comparison. Robust multicentre randomised trials are needed to establish parameter-specific guidelines for AFCL-PRP therapy.\n                  <\/jats:p>","DOI":"10.1007\/s10103-026-04860-1","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T01:13:29Z","timestamp":1776820409000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Platelet-rich plasma and ablative fractional carbon dioxide laser therapy for chronic scar management: a systematic review"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9048-1260","authenticated-orcid":false,"given":"Shonnelly","family":"Novintan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Campioni-Norman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shina","family":"Ardani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Frew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"4860_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/srt.13386","volume":"29","author":"L Liu","year":"2023","unstructured":"Liu L, Xue Y, Chen Y et al (2023) Prevalence and risk factors of acne scars in patients with acne vulgaris. Skin Res Technol 29:1\u20139. https:\/\/doi.org\/10.1111\/srt.13386","journal-title":"Skin Res Technol"},{"key":"4860_CR2","doi-asserted-by":"publisher","unstructured":"John W, Lawrence, Shawn T, Mason K, Schomer MB, Klein (January-February 2012) Epidemiology and Impact of Scarring After Burn Injury: A Systematic Review of the Literature. J Burn Care Res 33(1):136\u2013146. https:\/\/doi.org\/10.1097\/BCR.0b013e3182374452","DOI":"10.1097\/BCR.0b013e3182374452"},{"issue":"3","key":"4860_CR3","first-page":"71","volume":"18","author":"H De La Garza","year":"2025","unstructured":"De La Garza H et al (2025) The Impact of Acne Scarring on Quality of Life, Willingness-to-pay, and Time Trade-off: A Cross-sectional Analysis. J Clin Aesthetic Dermatol 18(3):71","journal-title":"J Clin Aesthetic Dermatol"},{"key":"4860_CR4","doi-asserted-by":"crossref","unstructured":"Zhou C et al (2023) Beyond the surface: a deeper look at the psychosocial impacts of acne scarring. Clin Cosmet Invest dermatology 16:731\u2013738","DOI":"10.2147\/CCID.S406235"},{"key":"4860_CR5","doi-asserted-by":"crossref","unstructured":"Bock O et al (2006) Quality of life of patients with keloid and hypertrophic scarring. Archives of dermatological research297.10 : 433\u2013438","DOI":"10.1007\/s00403-006-0651-7"},{"issue":"4","key":"4860_CR6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2165\/00128071-200304040-00004","volume":"4","author":"NE Van Loey","year":"2003","unstructured":"Van Loey NE, Van Son MJ (2003) Psychopathology and psychological problems in patients with burn scars: epidemiology and management. Am J Clin Dermatol 4(4):245\u2013272. https:\/\/doi.org\/10.2165\/00128071-200304040-00004PMID: 12680803.;","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"4860_CR7","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.burns.2017.03.009","volume":"43","author":"H Oh","year":"2017","unstructured":"Oh H, Boo S (2017) Quality of life and mediating role of patient scar assessment in burn patients. Burns 43(6):1212\u20131217. https:\/\/doi.org\/10.1016\/j.burns.2017.03.009","journal-title":"Burns"},{"key":"4860_CR8","doi-asserted-by":"crossref","unstructured":"Brewin MP, Homer SJ (2018) The lived experience and quality of life with burn scarring \u2013 the results from a large-scale online survey. Burns, 44(7), 1801\u20131810. DOI: 10.1016\/j.burns.2018.04.007 National Standards for Provision and Outcomes in Adult and Paediatric Burn Care. British Burn Association, 2018","DOI":"10.1016\/j.burns.2018.04.007"},{"key":"4860_CR9","unstructured":"National Standards for Provision and (2018) Outcomes in Adult and Paediatric Burn Care. British Burn Association"},{"key":"4860_CR10","unstructured":"NICE (2021) Acne vulgaris: management. https:\/\/www.nice.org.uk\/guidance\/ng198, (accessed 6th November 2025)"},{"issue":"8","key":"4860_CR11","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.bjps.2014.04.011","volume":"67","author":"S Monstrey","year":"2014","unstructured":"Monstrey S, Middelkoop E, Vranckx JJ, Bassetto F, Ziegler UE, Meaume S, Te\u00f3t L (2014) Updated scar management practical guidelines: non-invasive and invasive measures. J Plast Reconstr Aesthet Surg 67(8):1017\u20131025. https:\/\/doi.org\/10.1016\/j.bjps.2014.04.011","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"4860_CR12","doi-asserted-by":"publisher","unstructured":"Manuskiatti W, Triwongwaranat D, Varothai S, Eimpunth S, Wanitphakdeedecha R (2010) Efficacy and safety of a carbon-dioxide ablative fractional resurfacing device for treatment of atrophic acne scars in Asians. J Am Acad Dermatol 63(2):274\u2009\u2013\u200983. https:\/\/doi.org\/10.1016\/j.jaad.2009.08.051","DOI":"10.1016\/j.jaad.2009.08.051"},{"key":"4860_CR13","doi-asserted-by":"publisher","unstructured":"Arsiwala NZ, Inamadar AC, Adya KA (2020) A Comparative Study to Assess the Efficacy of Fractional Carbon Dioxide Laser and Combination of Fractional Carbon Dioxide Laser with Topical Autologous Platelet-rich Plasma in Post-acne Atrophic Scars. J Cutan Aesthet Surg 13(1):11\u201317. https:\/\/doi.org\/10.4103\/JCAS.JCAS_142_19","DOI":"10.4103\/JCAS.JCAS_142_19"},{"key":"4860_CR14","doi-asserted-by":"publisher","DOI":"10.1117\/1.3275479","volume":"14","author":"D Helbig","year":"2009","unstructured":"Helbig D, Bodendorf MO, Grunewald S et al (2009) Immunohistochemical investigation of wound healing in response to fractional photothermolysis. J Biomed Opt 14:064044","journal-title":"J Biomed Opt"},{"key":"4860_CR15","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1111\/j.1365-4632.2011.05029.x","volume":"50","author":"GJ Goodman","year":"2011","unstructured":"Goodman GJ (2011) Treatment of acne scarring. Int J Dermatol 50:1179\u20131194","journal-title":"Int J Dermatol"},{"issue":"2 Suppl 1","key":"4860_CR16","first-page":"3s","volume":"26","author":"A Lubkowska","year":"2012","unstructured":"Lubkowska A, Dolegowska B, Banfi G (2012) Growth factor content in PRP and their applicability in medicine. J Biol Regul Homeost Agents 26(2 Suppl 1):3s\u201322s","journal-title":"J Biol Regul Homeost Agents"},{"key":"4860_CR17","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.joms.2003.12.003","volume":"62","author":"RE Marx","year":"2004","unstructured":"Marx RE (2004) Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 62:489\u2013496","journal-title":"J Oral Maxillofac Surg"},{"key":"4860_CR18","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1177\/0363546509349921","volume":"37","author":"TE Foster","year":"2009","unstructured":"Foster TE, Puskas BL, Mandelbaum BR et al (2009) Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med 37:2259\u20132272","journal-title":"Am J Sports Med"},{"key":"4860_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovic J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, Emberson JR, Hernan MA, Hopewell S, Hrobjartsson A, Junqueira DR, Juni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"4860_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JAC Sterne","year":"2016","unstructured":"Sterne JAC, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, Carpenter JR, Chan AW, Churchill R, Deeks JJ, Hr\u00f3bjartsson A, Kirkham J, J\u00fcni P, Loke YK, Pigott TD, Ramsay CR, Regidor D, Rothstein HR, Sandhu L, Santaguida PL, Sch\u00fcnemann HJ, Shea B, Shrier I, Tugwell P, Turner L, Valentine JC, Waddington H, Waters E, Wells GA, Whiting PF, Higgins JPT (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919. https:\/\/doi.org\/10.1136\/bmj.i4919","journal-title":"BMJ"},{"issue":"2","key":"4860_CR21","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1080\/09546634.2019.1630701","volume":"32","author":"EM Abdel-Maguid","year":"2021","unstructured":"Abdel-Maguid EM, Awad SM, Hassan YS, El- Mokhtar MA, EL-Deek HE, Mekkawy MM (2021) Efficacy of stem cell-conditioned medium vs. platelet-rich plasma as an adjuvant to ablative fractional CO2 laser resurfacing for atrophic post-acne scars: a split-face clinical trial. J Dermatolog Treat 32(2):242\u2013249. https:\/\/doi.org\/10.1080\/09546634.2019.1630701","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"4860_CR22","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/jocd.12561","volume":"18","author":"A-AI Al Taweel","year":"2019","unstructured":"Al Taweel A-AI et al (2019) Comparative study of the efficacy of Platelet\u2010rich plasma combined with carboxytherapy vs its use with fractional carbon dioxide laser in atrophic acne scars. J Cosmet Dermatol 18(1):150\u2013155","journal-title":"J Cosmet Dermatol"},{"key":"4860_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/burnst\/tkab016","volume":"9","author":"Z Dai","year":"2021","unstructured":"Dai Z et al (2021) Combination of ablative fractional carbon dioxide laser and platelet-rich plasma treatment to improve hypertrophic scars: a retrospective clinical observational study. Burns Trauma 9:tkab016","journal-title":"Burns Trauma"},{"issue":"6","key":"4860_CR24","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1111\/jocd.12909","volume":"18","author":"O Galal","year":"2019","unstructured":"Galal O et al (2019) Fractional CO2 laser versus combined platelet-rich plasma and fractional CO2 laser in treatment of acne scars: image analysis system evaluation. J Cosmet Dermatol 18(6):1665\u20131671","journal-title":"J Cosmet Dermatol"},{"issue":"5","key":"4860_CR25","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1080\/09546634.2022.2067816","volume":"33","author":"HI Gawdat","year":"2022","unstructured":"Gawdat HI, El-Hadidy YA, Allam RSHM, Abdelkader HA (2022) Autologous platelet-rich plasma \u2018fluid\u2019 versus \u2018gel\u2019 form in combination with fractional CO2 laser in the treatment of atrophic acne scars: a split- face randomized clinical trial. J Dermatolog Treat 33(5):2654\u20132663. https:\/\/doi.org\/10.1080\/09546634.2022.2067816","journal-title":"J Dermatolog Treat"},{"issue":"2","key":"4860_CR26","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/dsu.12392","volume":"40","author":"HI Gawdat","year":"2014","unstructured":"Gawdat HI et al (2014) Autologous platelet rich plasma: topical versus intradermal after fractional ablative carbon dioxide laser treatment of atrophic acne scars. Dermatol Surg 40(2):152\u2013161","journal-title":"Dermatol Surg"},{"key":"4860_CR27","doi-asserted-by":"publisher","first-page":"930","DOI":"10.4103\/idoj.IDOJ_174_20","volume":"11","author":"S Godara","year":"2020","unstructured":"Godara S, Arora S, Dabas R, Arora G, Renganathan G, Choudhary R (2020) A comparative study on the efficacy of fractional CO2 laser and fractional CO2 laser with autologous platelet-rich plasma in scars. Indian Dermatol Online J 11:930\u2013936","journal-title":"Indian Dermatol Online J"},{"issue":"3","key":"4860_CR28","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/jocd.15501","volume":"22","author":"R Guo","year":"2023","unstructured":"Guo R et al (2023) Safety and efficacy of CO2 dot matrix laser combined with platelet-rich plasma on depressed scar after acne vulgaris and influencing factors of its repair effect: A retrospective analysis. J Cosmet Dermatol 22(3):850\u2013861","journal-title":"J Cosmet Dermatol"},{"key":"4860_CR29","first-page":"136","volume":"10","author":"BR Kar","year":"2018","unstructured":"Kar BR, Raj C (2018) Fractional CO2 laser vs fractional CO2 with topical platelet-rich plasma in the treatment of acne scars: A split-face comparison trial. J Cutan Aesthet Surg 10:136\u2013144","journal-title":"J Cutan Aesthet Surg"},{"key":"4860_CR30","doi-asserted-by":"publisher","first-page":"371","DOI":"10.4103\/idoj.idoj_462_22","volume":"14","author":"D Priya","year":"2023","unstructured":"Priya D, Patil S (2023) A split face comparative interventional study to evaluate the efficacy of fractional carbon dioxide laser against combined use of fractional carbon dioxide laser and platelet\u2013rich plasma in the treatment of acne scars. Indian Dermatol Online J 14:371\u2013374","journal-title":"Indian Dermatol Online J"},{"issue":"7","key":"4860_CR31","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/j.1524-4725.2011.01999.x","volume":"37","author":"JW Lee","year":"2011","unstructured":"Lee JW et al (2011) The efficacy of autologous platelet rich plasma combined with ablative carbon dioxide fractional resurfacing for acne scars: a simultaneous split-face trial. Dermatol Surg 37(7):931\u2013938","journal-title":"Dermatol Surg"},{"issue":"1","key":"4860_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00403-025-04112-2","volume":"317","author":"MA Rageh","year":"2025","unstructured":"Rageh MA et al (2025) Fractional CO2 laser with topical insulin versus PRP for atrophic acne scars: a randomized split-face study. Arch Dermatol Res 317(1):1\u20139","journal-title":"Arch Dermatol Res"},{"key":"4860_CR33","doi-asserted-by":"publisher","unstructured":"Sharma N (July 2025) Efficacy of Fractional CO\u2082 Laser With and Without Platelet-Rich Plasma in Atrophic Acne Scars: A Split-Face Comparative Study. Int J Life Sci Biotechnol Pharma Res Vol 14(7). https:\/\/doi.org\/10.69605\/ijlbpr_14.7.2025.218","DOI":"10.69605\/ijlbpr_14.7.2025.218"},{"key":"4860_CR34","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4103\/JCAS.JCAS_147_19","volume":"14","author":"S Sharma","year":"2021","unstructured":"Sharma S, Kaur J, Kaur T, Bassi R (2021) Fractional carbon dioxide laser versus combined fractional carbon dioxide laser with platelet-rich plasma in the treatment of atrophic post-acne scars: a split-face comparative study. J Cutan Aesthet Surg 14:41\u201346","journal-title":"J Cutan Aesthet Surg"},{"key":"4860_CR35","doi-asserted-by":"crossref","unstructured":"Solanki A, Dhinoja N (2020) A Split Face Comparative Study of Microneeding with Platelet Rich Plasma Versus Fractional CO2 Laser with Platelet Rich Plasma in Management of Atrophic Acne Scars. Zenodo (CERN European Organization for Nuclear Research). CERN European Organization for Nuclear Research","DOI":"10.26860\/IJABMS.2020.22\/B.35.2"},{"key":"4860_CR36","unstructured":"Rahman S, Naveed T, Afridi IU, Suhail MA, Khan DD, Khan M, Shiraz Z Comparison of efficacy of micro-needling plus platelet-rich plasma and fractional CO2 laser plus platelet-rich plasma in the treatment of post-acne scars. J Pak Assoc Dermatol [Internet]. 2024Dec.31 [cited 2025Nov.20];34(4 Suppl.):S83-S88. Available from: https:\/\/www.jpad.com.pk\/index.php\/jpad\/article\/view\/3051"},{"key":"4860_CR37","doi-asserted-by":"publisher","DOI":"10.3310\/nihropenres.13234.1","volume":"2","author":"M Brewin","year":"2022","unstructured":"Brewin M, Docherty S, Heaslip V, Breheny K, Pleat J, Rhodes S (2022) Early laser for burn scars (ELABS): protocol for a multi-centre randomised, controlled trial of both the effectiveness and cost-effectiveness of the treatment of hypertrophic burn scars with Pulsed Dye Laser and standard care compared to standard care alone. NIHR Open Res 2:1. https:\/\/doi.org\/10.3310\/nihropenres.13234.1","journal-title":"NIHR Open Res"},{"issue":"9","key":"4860_CR38","doi-asserted-by":"publisher","first-page":"e0285230","DOI":"10.1371\/journal.pone.0285230","volume":"18","author":"Y-Y Chen","year":"2023","unstructured":"Chen Y-Y, Patel KM, Imran R, Hassouna T, Amirize E, Abdulsalam A, Bishop J, Slade A, Ventura M, Yarrow J, Lord JM, Wilson Y, Moiemen NS (2023) SMOOTH protocol: A pilot randomised prospective intra-patient single-blinded observational study for examining the mechanistic basis of ablative fractional carbon dioxide laser therapy in treating hypertrophic scarring. PLoS ONE 18(9):e0285230. https:\/\/doi.org\/10.1371\/journal.pone.0285230","journal-title":"PLoS ONE"},{"issue":"1","key":"4860_CR39","first-page":"118","volume":"20","author":"G Weibrich","year":"2005","unstructured":"Weibrich G, Kleis WK, Hitzler WE, Hafner G (2005) Comparison of point-of-care methods for preparation of platelet concentrate (platelet-rich plasma). Int J Oral Maxillofac Implants 20(1):118\u2013123 PubMed ID: 22848876","journal-title":"Int J Oral Maxillofac Implants"},{"issue":"2","key":"4860_CR40","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1177\/0363546510387517","volume":"39","author":"TN Castillo","year":"2010","unstructured":"Castillo TN, Pouliot MA, Kim HJ, Dragoo JL (2010) Comparison of growth factor and platelet concentration from commercial platelet-rich plasma separation systems. Am J Sports Med 39(2):266\u2013271","journal-title":"Am J Sports Med"},{"key":"4860_CR41","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1046\/j.1537-2995.2001.41101217.x","volume":"41","author":"R Zimmerman","year":"2001","unstructured":"Zimmerman R, Jakubietz R, Jacubietz M et al (2001) Different preparation methods to obtain platelet components as a source of growth factors for local application. Transfusion 41:1217\u20131224","journal-title":"Transfusion"}],"container-title":["Lasers in Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-026-04860-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10103-026-04860-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-026-04860-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:31:28Z","timestamp":1781649088000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10103-026-04860-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4860"],"URL":"https:\/\/doi.org\/10.1007\/s10103-026-04860-1","relation":{},"ISSN":["1435-604X"],"issn-type":[{"value":"1435-604X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable as this is a systematic review of published data.\u00a0","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate\u00a0declaration"}},{"value":"An\u00a0ethics approval\u00a0is not applicable because this study is based exclusively on published literature.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval\u00a0"}},{"value":"Not applicable.\u00a0","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}